Characteristics of new contraceptive users in patients with SCD with and without TE
| Characteristic . | TE . | No TE . | P . |
|---|---|---|---|
| Unique patients | 126 | 7047 | |
| Mo, continuous enrollment, median, (IQR) | 82 (46-122) | 75 (38-120) | .353 |
| Mo, washout period, median, (IQR) | 24 (15-42) | 26 (13-56) | .347 |
| Total SCD claims, n (IQR) | 145 (35-391) | 26 (7-103) | <.001 |
| Age, median (IQR), y | 25.4 (22.0-29.8) | 22.1 (18.4-27.7) | <.001 |
| Age group, median (IQR) | <.001 | ||
| 12-18 y | 11 (8.7) | 2090 (29.7) | |
| 19-26 y | 68 (54.0) | 3040 (43.1) | |
| 27-34 y | 32 (25.4) | 1349 (19.1) | |
| 35-44 y | 15 (11.9) | 568 (8.1) | |
| Sickle cell genotype, n (%) | <.001 | ||
| Hb SS | 99 (78.6) | 4598 (65.2) | |
| Hb SC | 8 (6.3) | 723 (10.3) | |
| Hb Sβ0/+ | 12 (9.5) | 739 (10.5) | |
| Nonspecific SCD | 7 (5.6) | 987 (14.0) | |
| SCD severity, n (%) | <.001 | ||
| High | 61 (48.4) | 987 (14.0) | |
| Low | 65 (51.6) | 6060 (86.0) | |
| Comorbid conditions, n (%) | |||
| Obesity | 14 (11.1) | 352 (5.0) | .002 |
| Smoking | 10 (7.9) | 307 (4.4) | .053 |
| Diabetes | 11 (8.7) | 189 (2.7) | <.001 |
| Hypertension | 28 (22.2) | 569 (8.1) | <.001 |
| Hyperlipidemia | 5 (4.0) | 129 (1.8) | .087 |
| Cancer | 4 (3.2) | 115 (1.6) | .157 |
| Characteristic . | TE . | No TE . | P . |
|---|---|---|---|
| Unique patients | 126 | 7047 | |
| Mo, continuous enrollment, median, (IQR) | 82 (46-122) | 75 (38-120) | .353 |
| Mo, washout period, median, (IQR) | 24 (15-42) | 26 (13-56) | .347 |
| Total SCD claims, n (IQR) | 145 (35-391) | 26 (7-103) | <.001 |
| Age, median (IQR), y | 25.4 (22.0-29.8) | 22.1 (18.4-27.7) | <.001 |
| Age group, median (IQR) | <.001 | ||
| 12-18 y | 11 (8.7) | 2090 (29.7) | |
| 19-26 y | 68 (54.0) | 3040 (43.1) | |
| 27-34 y | 32 (25.4) | 1349 (19.1) | |
| 35-44 y | 15 (11.9) | 568 (8.1) | |
| Sickle cell genotype, n (%) | <.001 | ||
| Hb SS | 99 (78.6) | 4598 (65.2) | |
| Hb SC | 8 (6.3) | 723 (10.3) | |
| Hb Sβ0/+ | 12 (9.5) | 739 (10.5) | |
| Nonspecific SCD | 7 (5.6) | 987 (14.0) | |
| SCD severity, n (%) | <.001 | ||
| High | 61 (48.4) | 987 (14.0) | |
| Low | 65 (51.6) | 6060 (86.0) | |
| Comorbid conditions, n (%) | |||
| Obesity | 14 (11.1) | 352 (5.0) | .002 |
| Smoking | 10 (7.9) | 307 (4.4) | .053 |
| Diabetes | 11 (8.7) | 189 (2.7) | <.001 |
| Hypertension | 28 (22.2) | 569 (8.1) | <.001 |
| Hyperlipidemia | 5 (4.0) | 129 (1.8) | .087 |
| Cancer | 4 (3.2) | 115 (1.6) | .157 |